Paper Details 
Original Abstract of the Article :
Cefdinir (CFDN), a new oral cephalosporin, was administered to 10 patients with various infections and the following results were obtained. 1. Clinical responses in 10 patients (1 patient with rhinitis, 2 with sinusitis, 1 with pharyngitis, 1 with tonsillitis, 4 with scarlet fever and 1 with abscess...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2283713

データ提供:米国国立医学図書館(NLM)

Cefdinir: A Promising Oral Cephalosporin for Pediatric Infections

Antibiotics play a vital role in treating bacterial infections, particularly in children. This study evaluates the efficacy and safety of cefdinir (CFDN), a new oral cephalosporin, in the treatment of various pediatric infections. The researchers administered cefdinir to 10 children with different infections, assessing clinical response, bacterial eradication, and potential side effects.

Cefdinir: Effective and Safe for Children

The study found that cefdinir was highly effective in treating a range of pediatric infections, with excellent or good clinical responses in all patients. Notably, cefdinir eradicated all isolated bacterial species without any reported side effects.

A Desert Oasis of Healing

Think of a desert oasis, a place where weary travelers find relief and rejuvenation. Similarly, antibiotics can offer a haven of healing for those battling infections. This research showcases the effectiveness and safety of cefdinir in treating pediatric infections, offering a valuable tool for doctors in their fight against bacterial disease.

Dr.Camel's Conclusion

This study demonstrates the effectiveness and safety of cefdinir in treating a variety of pediatric infections. The research highlights cefdinir's potential as a valuable addition to the arsenal of antibiotics used to combat bacterial infections in children.

Date :
  1. Date Completed 1991-03-18
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

2283713

DOI: Digital Object Identifier

2283713

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.